FDA approves a new drug to treat the underlying cause of cystic fibrosis. Eventually, it might help nearly half of the 30,000 people in the United States living with the deadly lung disease.
Cystic Fibrosis Foundation’s success demonstrates the potential payoffs and perils of “venture philanthropy.”
The Centers for Disease Control and Prevention last year reported that calls to poison centers across the country involving e-cigarettes had surged.
Researchers in North Carolina are developing a “smart” insulin patch that can automatically detect and manage blood sugar levels.
New device helps blind people “see” with their tongues.
“Science won out,” said Fred Kummerow, who sued the agency in 2013 for not acting sooner.
Agency says move will prevent thousands of heart attack deaths each year.
Researchers are studying the genes of unique patients for clues that could lead to better treatments.
A new class of medications could sharply cut the risk of heart attacks and strokes.
A federal panel will decide this week whether to recommend approval of the cholesterol drugs, which an expert hailed as “one of the biggest developments in a long time in cardiology.”